Amount Raised
$4.5 Million
Round Type
Seed
New YorkBiotechnologyBiotechnology ResearchInvestors
Description
C16 Biosciences, makers of Palmless™, is ramping up its capabilities in the food category, fueled by a $3.5 million grant from the Bill & Melinda Gates Foundation as well as a $1 million investment from Elemental Excelerator. The company will use the funding to expand the Palmless™ platform by working with non-agriculturally derived feedstocks to produce food-grade oils and fats, unlocking a circular economy model capable of producing food products and ingredients without dependence on arable land.
Quick answer
C16 Biosciences raised $4.5 Million in a Seed round, dated January 24, 2024. Investors: Elemental Excelerator and Bill & Melinda Gates Foundation. C16 Biosciences is based in New York, New York, United States.
- How much did C16 Biosciences raise?
- C16 Biosciences raised $4.5 Million in a Seed round on January 24, 2024.
- Who invested in C16 Biosciences?
- Elemental Excelerator and Bill & Melinda Gates Foundation are named as investors in this round.
- What does C16 Biosciences do?
- C16 Biosciences is a New York-based biotech company producing biodesigned performance ingredients.
- Where is C16 Biosciences based and how big is it?
- C16 Biosciences is based in New York, New York, United States.
- Who are the decision-makers at C16 Biosciences?
- Fundz holds 1 contact at C16 Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology Research and Biotechnology around the same time
Companies in the same sectors as C16 Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Sudo Biosciences raised $147M (Series B) on February 13, 2024.
- Thunder Biotech raised $100K (Seed) on February 9, 2024.
- BlueWillow Biologics raised $850K (Seed) on January 30, 2024.
- BioGen raised $95M (Series B) on January 4, 2024.
- Liquidia raised $100M (Funding Round) on January 4, 2024.
- Apollo Therapeutics Group Limited raised an undisclosed amount (Series C) on January 2, 2024.
Who to call at C16 Biosciences, and when
A new round usually means C16 Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day C16 Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at C16 Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at C16 Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment C16 Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
C16 Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.